GLP-1 demand is straining pharma cold chain capacity, from tighter temperature thresholds and rising load rejections to fuel costs and trailer backlogs.
|Articles|March 24, 2015
Marken opens a Shanghai branch office for clinical logistics
Office will serve Shanghai and Suzhou life sciences clients
Advertisement
Marken (Research Triangle Park, NC) has opened a branch office in Shanghai; in China, it is now represented with branch offices in Hong Kong and Beijing, and a depot in Beijing. The new Shanghai office is close to Hongqiao and Pudong airports, and the company says that it is adding temperature-controlled vehicles to provide ground transportation. The Chinese government has granted a 12-year license to the firm.
Advertisement
Related to this article
Eutecma's Tempaid buy pairs reusable bulk shippers with last-mile mailers as smaller, more frequent refrigerated shipments reshape demand.
Copeland's Dickson buy adds cloud-native monitoring as the pharma cold chain moves toward continuous visibility to meet rising regulatory demands.
In this week's Pharma Pulse, Vicapsys merges with Stateline, Veritiv targets GLP-1 shipping, Section 232 tariffs widen and HRSA's 340B rebate pilot deadline arrives.
Temperature excursions cost pharma an estimated $35 billion a year as biologics, GLP-1s and cell and gene therapies raise cold chain stakes.
Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
At LogiPharma USA 2026, quality leaders explained why connected data, risk-based prioritization, and human accountability must come before AI in supply chain compliance.
Swisslog's Mark Beers discusses how software helps pharma supply chains adapt to shifting portfolios, strengthen inventory verification and build trust.
Advertisement
Advertisement